Table 1.
Percentages of CD3+ cells expressing the various HLA class I-specific inhibiting NKRs in HIV-1-infected patients
| Patient | % T lymphocytes expressing NKRs
|
|||
|---|---|---|---|---|
| p58.1 | p58.2 | p70 | CD94/NKG2 | |
| 1 | 24 | 34 | 32 | 18 |
| 2 | 11 | 12 | 13 | 12 |
| 3 | 2 | 3 | 3 | 4 |
| 4 | 2 | 9 | 9 | 5 |
| 5 | ND | 3 | 7 | 6 |
| 6 | 0 | 5 | 3 | 5 |
| 7 | 4 | 7 | 4 | 8 |
| 8 | 5 | 8 | 7 | 6 |
| 9 | 13 | 20 | 17 | 19 |
| 10 | 8 | 3 | 1 | 14 |
| 11 | 12 | 36 | 14 | 16 |
| 12 | 14 | 11 | 4 | 7 |
| 13 | 1 | 7 | 2 | 2 |
| 14 | 15 | 17 | 12 | 2 |
Numbers express the percentage of CD3+ cells expressing a given NKRs, as evaluated by double fluorescence and FACS analysis. ND, not determined.